Cetuximab-800CW
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Cetuximab-800CW, covering 2026-04-13 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Oral Bevacizumab-800CW and Cetuximab-800CW Administration to Detect Early Esophageal Adenocarcinomas [Phase 2]